Lijing

Head of the Department of Microbiology and Synthetic Biology, Professor, and Doctoral Supervisor. The target audience for cultivating young and middle-aged academic leaders in the Green and Blue Project in Jiangsu Province. In the past 5 years, as the corresponding author or first author in Gut (IF 30.2), Published articles in top tier or disciplinary journals such as Gastroenterology (IF=19.2), Microbiome (IF 16.8), Sci. Adv. (IF 12.8), etc., achieving excellent scientific research results. I am currently the associate editor of the important journal Frontiers Microbiology, a member of the Gut Microbiota Branch of the Chinese Biophysics Society, a member of the Pharmacogenomics Professional Committee of the Chinese Pharmacological Society, and a member of the Jiangsu Molecular Nutrition Branch Special Committee of the Chinese Nutrition Society. He has presided over three general projects of the National Natural Science Foundation of China, participated in one major new drug development project of the national science and technology major project, participated in one major research and development plan project of the Chinese People's Liberation Army during the 13th Five Year Plan, presided over many provincial projects such as the development project of key laboratories in Hunan Province, presided over many horizontal research projects of Jiangsu Kaiyuan Pharmaceutical Co., Ltd., and received more than 3 million yuan of competitive project funds in recent five years.

1. Haijian Sun, Yunke Guo, Haidan Wang, Ailing Yin, Jing Hu, Tianjie Yuan,  Shuxin Zhou, Weichen Xu, Peng Wei, Shusheng Yin, Panru Liu, Xi Guo, Yizhao Tang, Yujiao Yan, Zichen Luo, Majie Wang, Qingqing Liang, Peng Wu, Aifeng Zhang, Zhuxiu Zhou, Yueyue Chen, Yongming Li, Jing Li* , Jinjun Shan*, Wei Zhou*, Gut commensal Parabacteroides distasonis alleviates inffammatory arthritis, Gut, 2023, 72(9):1664-1677.

2. Zheng-Meng Jiang, Su-Ling Zeng, Tian-Qing Huang, Yang Lin, Fang-Fang Wang, Xing-Jiao Gao, Jing Li*, Ping Li*, E-Hu Liu*. Sinomenine ameliorates rheumatoid arthritis by modulating tryptophan metabolism and activating aryl hydrocarbon receptor via gut microbiota regulation, Sci Bull (Beijing), 2023, 68(14):1540-1555.

3. Ziwei Song, Shuo Feng, Xingchen Zhou, Zhengxing Song, Jing Li*, Ping Li*. Taxonomic identification of bile salt hydrolase-encoding lactobacilli: Modulation of the enterohepatic bile acid profile, iMeta, 2023. e128

4. Cai, Yuan-Yuan, Feng-Qing Huang, Xingzhen Lao, Yawen Lu, Xuejiao Gao, Raphael N. Alolga, Kunpeng Yin, Xingchen Zhou, Yun Wang, Baolin Liu, Jing Shang*, Lian-Wen Qi*, and Jing Li*. 2022. Integrated metagenomics identifies a crucial role for trimethylamine-producing Lachnoclostridium in promoting atherosclerosis, npj Biofilms and Microbiomes, 2022, 8(1):11

5. Su-Ling Zeng^#, Shang-Zhen Li^#, Ping-Ting Xiao, Yuan-Yuan Cai, Chu Chu, Bai-Zhong Chen, Ping Li*, Jing Li*, E-Hu Liu*, Citrus polymethoxyflavones attenuate metabolic syndrome by regulating gut microbiome and amino acid metabolism, Science Advance, 2020, 6:eaax6288

6. Jiankang Li^#, Jing Li^#, Huan Wang, Lian-Wen Qi, Yimin Zhu, Maode Lai, Tyrosine and Glutamine–leucine are Metabolic Markers of Early-stage Colorectal Cancers, Gastroenterology, 2019, 157:257-259 .

7. Ziwei Song^#, Yuanyuan Cai^#, Xingzhen Lao, Xue Wang, Xiaoxuan Lin, Yingyun Cui, Praveen Kumar Kalavagunta, Jun Liao, Liang Jin*, Jing Shang*, Jing Li*, Taxonomic profiling and populational patterns of bacterial bile salt hydrolase (BSH) genes based on worldwide human gut microbiome, Microbiome, 2019, 7(1):9.

8. Ziwei Song^#, Xue Wang^#, Xingchen Zhou, Su Jiang, Yuanyuan Li, Owais Ahmad, Lianwen Qi, Ping Li*, Jing Li*, Taxonomic Distribution of FosB in Human-Microbiota and Activity Comparison of Fosfomycin Resistance, Frontiers in Microbiology, 2019, 10:200.

1. General Project of National Natural Science Foundation of China, 31370505, Macrogenomic Study on the Composition and Structure of Gut Microbiota in Different Populations in China and Its Influencing Factors and Mechanisms, 2014/01-2017/12, 860000 yuan, completed and led.

2. General Project of National Natural Science Foundation of China, 31670495, Research on the Natural Selection Mechanism of Carbohydrates on CAZy Enzyme Gene Polymorphism in Intestinal Microbiota and the Regulation of Microbial Structure, 2017/01-2020/12, 620000 yuan, completed and led

3. General Project of National Natural Science Foundation of China, 3217010257, Mechanism Study on the Regulation of Binding/Free Bile Acid Pools by Bile Water Hydrolyzing Enzyme containing Bacteria and Their Impact on Changes in Intestinal Microbial Structure, 2022/01-2026/12, 580000 yuan, in progress, principal investigator.

4. National Science and Technology Major Special Project for Major New Drug Creation, 2019X09301-156, Innovative Chinese Medicine Preclinical Research on Treating Lipid Metabolism Disorders with Cichorium sibiricum, 2019/01-2020/12, 200000 yuan, completed, participated in (sub project leader)

5. Jiangsu Province Industry University Research Cooperation Project, exploring drug therapy targets for invasive fungi based on genetic characteristics and screening related small molecule drugs, with a budget of 300000 yuan from September 2022 to September 2025, under research and led by.

6. Enterprise research project, jointly built by China Pharmaceutical University and Jiangsu Kaiyuan Pharmaceutical Co., Ltd. Laboratory, with a budget of 1.5 million yuan from May 2022 to April 2025, under research and led by.

7. Enterprise research project, China Pharmaceutical University Shanghai Yunsheng Yanxin Biotechnology Co., Ltd. Joint Laboratory of Biological Delivery, 2023/6/8-2028/6/8, 1.5 million yuan, under research, led by.

8. Enterprise scientific research project, 8190040038, research on the biological characteristics of important yeast, 2019/10-2020/11, 500000, completed and led.